Title:
CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO GPC3 AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/246578
Kind Code:
A1
Abstract:
A chimeric antigen receptor specifically binding to GPC3, a modified immune cell expressing the chimeric antigen receptor, and a method for preparing the modified immune cell. These chimeric antigens and immune cells are used for a method for preventing and/or treating diseases associated with GPC3 expression.
Inventors:
SONG TINGYU (CN)
HOU PANYAN (CN)
ZHOU YANG (CN)
CAI ZHENZHEN (CN)
WANG JIANGMAN (CN)
GE JUNYOU (CN)
HOU PANYAN (CN)
ZHOU YANG (CN)
CAI ZHENZHEN (CN)
WANG JIANGMAN (CN)
GE JUNYOU (CN)
Application Number:
PCT/CN2023/100146
Publication Date:
December 28, 2023
Filing Date:
June 14, 2023
Export Citation:
Assignee:
CHENGDU KELUN PREC BIOTECHNOLOGY CO LTD (CN)
International Classes:
A61K39/395; A61K35/17; A61P35/00; C12N5/078; C12N15/63
Foreign References:
| US20180346592A1 | 2018-12-06 | |||
| US20180044424A1 | 2018-02-15 | |||
| CN113396161A | 2021-09-14 | |||
| CN111592594A | 2020-08-28 | |||
| CN102482342A | 2012-05-30 | |||
| CN111683962A | 2020-09-18 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: